AIM:INHC

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Induction Healthcare Group

Executive Summary

Induction Healthcare Group PLC provides software to healthcare professionals in the United Kingdom, rest of Europe, the United States, and internationally. More Details


Snowflake Analysis

Flawless balance sheet and overvalued.

Share Price & News

How has Induction Healthcare Group's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: INHC is not significantly more volatile than the rest of UK stocks over the past 3 months, typically moving +/- 9% a week.

Volatility Over Time: INHC's weekly volatility (9%) has been stable over the past year.


Market Performance


7 Day Return

0%

INHC

7.4%

GB Healthcare Services

1.2%

GB Market


1 Year Return

-25.5%

INHC

7.3%

GB Healthcare Services

-9.6%

GB Market

Return vs Industry: INHC underperformed the UK Healthcare Services industry which returned 7.3% over the past year.

Return vs Market: INHC underperformed the UK Market which returned -9.1% over the past year.


Shareholder returns

INHCIndustryMarket
7 Day0%7.4%1.2%
30 Day-5.4%12.2%8.6%
90 Day-1.7%6.9%5.4%
1 Year-25.5%-25.5%9.4%7.3%-6.1%-9.6%
3 Yearn/a31.8%24.4%-0.6%-12.6%
5 Yearn/a31.2%19.5%23.3%-4.4%

Long-Term Price Volatility Vs. Market

How volatile is Induction Healthcare Group's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Induction Healthcare Group undervalued compared to its fair value and its price relative to the market?

2.08x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate INHC's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate INHC's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: INHC is unprofitable, so we can't compare its PE Ratio to the XE Healthcare Services industry average.

PE vs Market: INHC is unprofitable, so we can't compare its PE Ratio to the UK market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate INHC's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: INHC is good value based on its PB Ratio (2.1x) compared to the GB Healthcare Services industry average (4.8x).


Next Steps

Future Growth

How is Induction Healthcare Group forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

22.7%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Induction Healthcare Group has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has Induction Healthcare Group performed over the past 5 years?

-40.8%

Last years earnings growth


Earnings and Revenue History

Quality Earnings: INHC is currently unprofitable.

Growing Profit Margin: INHC is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: Unable to establish if INHC's year-on-year earnings growth rate was positive over the past 5 years as it has been trading publicly for less than 3 years.

Accelerating Growth: Unable to compare INHC's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: INHC is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (-14.6%).


Return on Equity

High ROE: INHC has a negative Return on Equity (-28.34%), as it is currently unprofitable.


Next Steps

Financial Health

How is Induction Healthcare Group's financial position?


Financial Position Analysis

Short Term Liabilities: INHC's short term assets (£10.9M) exceed its short term liabilities (£2.1M).

Long Term Liabilities: INHC's short term assets (£10.9M) exceed its long term liabilities (£359.0K).


Debt to Equity History and Analysis

Debt Level: INHC is debt free.

Reducing Debt: INHC had no debt 5 years ago.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: INHC has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: INHC has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of 58.1% each year


Next Steps

Dividend

What is Induction Healthcare Group current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate INHC's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate INHC's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if INHC's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if INHC's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of INHC's dividend in 3 years as they are not forecast to pay a notable one for the UK market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

0.5yrs

Average management tenure


CEO

Hugo Stephenson

0.42

Tenure

Dr. Hugo Stephenson, M. D., is Interim Head of Product/Development at Induction Healthcare Group PLC since October 2019 and serves as its Chief Executive Officer since March 02, 2020. Dr. Stephenson serves...


Leadership Team

NamePositionTenureCompensationOwnership
Hugo Stephenson
CEO, Interim Head of Product & Development and Executive Director0.42yrno data21.15%
£ 7.8m
James Balmain
CEO & Executive Director0.42yrno data1.66%
£ 612.0k
Shelley Kim Fraser
CFO & Executive Director0.67yrno datano data
Dale Jessop
Chief Technology Officerno datano data1.56%
£ 573.3k
Lloyd Price
Group Head of Marketing & Communicationsno datano datano data
Ibraheem Mahmood
Chief Business Officer0.67yrno data9.2%
£ 3.4m

0.5yrs

Average Tenure

Experienced Management: INHC's management team is not considered experienced ( 0.5 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Hugo Stephenson
CEO, Interim Head of Product & Development and Executive Director0.42yrno data21.15%
£ 7.8m
James Balmain
CEO & Executive Director0.42yrno data1.66%
£ 612.0k
Shelley Kim Fraser
CFO & Executive Director0.67yrno datano data
Leslie-Ann Reed
Independent Non-Executive Director1.33yrsno datano data
Jane Silber
Independent Non-Executive Director1.58yrsno data0.021%
£ 7.6k
Christopher Spencer
Independent Non-Executive Chairman1.58yrsno data0.021%
£ 7.6k
Andrew Williams
Non-Executive Director0.42yrno data1.0%
£ 367.1k

1.3yrs

Average Tenure

57.5yo

Average Age

Experienced Board: INHC's board of directors are not considered experienced ( 1.3 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 41.9%.


Top Shareholders

Company Information

Induction Healthcare Group PLC's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Induction Healthcare Group PLC
  • Ticker: INHC
  • Exchange: AIM
  • Founded: 2019
  • Industry: Health Care Technology
  • Sector: Healthcare
  • Market Cap: UK£36.794m
  • Shares outstanding: 42.05m
  • Website: https://www.inductionhealthcare.com

Number of Employees


Location

  • Induction Healthcare Group PLC
  • 20 St. Dunstan’s Hill
  • London
  • Greater London
  • EC3R 8HL
  • United Kingdom

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
INHCAIM (London Stock Exchange AIM Market)YesOrdinary SharesGBGBPMay 2019

Biography

Induction Healthcare Group PLC provides software to healthcare professionals in the United Kingdom, rest of Europe, the United States, and internationally. It offers Induction Switch, a communication and s...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/11/23 22:16
End of Day Share Price2020/11/23 00:00
Earnings2020/03/31
Annual Earnings2020/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.